• Users Online: 472
  • Print this page
  • Email this page
Year : 2018  |  Volume : 29  |  Issue : 5  |  Page : 237-242

Comparison of urodynamic bladder dysfunction in male patients with pelvic organ malignancies

1 Division of Urology, Department of Surgery, Chi Mei Medical Center; Min-Hwei College of Health Care Management, Liouying, Tainan, Taiwan
2 Department of Nursing, National Cheng Kung University Hospital, Liouying, Tainan, Taiwan
3 Department of Environmental and Occupational Health, College of Medicine, National Cheng Kung University; Division of Hematology-Oncology, Department of Internal Medicine, Chi Mei Medical Center, Liouying, Tainan, Taiwan
4 Division of Urology, Department of Surgery, Chi Mei Medical Center, Liouying, Tainan; Department of Information Management System, National Chung Cheng University, Chiayi, Taiwan

Correspondence Address:
Chih-Cheng Lu
Department of Surgery, Division of Urology, Chi Mei Medical Center, No. 201, Taikang, Liouying, Tainan 736
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/UROS.UROS_30_18

Rights and Permissions

Objective: Bladder dysfunction is a common complication after pelvic cancer treatments (radical pelvic surgery or chemoradiotherapy) that may affect patient satisfaction and quality of life. The aim of this study is to compare urodynamic bladder dysfunction among male patients with different pelvic organ malignancies (POMs). Materials and Methods: Data were collected from male patients with POM undergoing urodynamic studies (UDSs). Patients were stratified into three groups based on the origin of cancer (prostate, bladder, and colorectum). Selected data, including age, clinical tumor staging, lower urinary tract symptoms or acute urinary retention, and the parametric values of UDSs, were compared among the groups. SPSS 17.0.1 for Windows and Microsoft Office Excel 2007 were used for all statistical analysis. Results: A total of 640 patients with POM from the prostate (40.9%), bladder (33.5%), and colorectum (25.6%) were investigated. Patient age ranged from 39 to 89 years (mean 72.93 ± 9.08 years). In uroflowmetry (525 patients), the maximal urine flow rate was significantly lower in the prostate group (11.49 ± 5.53 ml/s). Cystometrograms (115 patients) showed that the first desire was more sensitive in the bladder group (85.52 ± 49.78 ml). Cystometric capacity was decreased in the prostate group (161.50 ± 94.29 ml); the maximum voiding pressure and compliance were significantly lower in the colorectum group (64.58 ± 50.09 cmH2O). Conclusion: Patients with POM may suffer from urination dysfunction. Impaired bladder function is more predominant in the colorectum oncology compared with urological pelvic organ (prostate or bladder) malignancies. Physicians are encouraged to be aware of these urinary complications after POM treatment.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded325    
    Comments [Add]    

Recommend this journal